...
首页> 外文期刊>Journal of clinical virology: The official publication of the Pan American Society for Clinical Virology >HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.
【24h】

HIV-1 mother-to-child transmission and drug resistance among Brazilian pregnant women with high access to diagnosis and prophylactic measures.

机译:HIV-1母婴传播和耐药性在巴西孕妇中很容易获得诊断和预防措施。

获取原文
获取原文并翻译 | 示例

摘要

A high-coverage public health prenatal program (70,000 women/year) from central western Brazil/Goias State has represented a unique opportunity for the early diagnosis of HIV-1 and implementation of strategies to prevent mother-to-child transmission (MTCT).To investigate MTCT among a prospective cohort of HIV-1 infected mothers/exposed infants.142 mothers/their 149 infants (2008-2010) were investigated regarding maternal viral load, CD4(+)cell counts, HIV-1 pol sequences; infants' HIV-1 RNA tests (30/120 days), sequential anti-HIV-1/2 serology. HIV-1 subtypes were assigned by REGA. Transmitted drug resistance was identified by the Calibrated Population Resistance tool, secondary resistance by Stanford HIV-1 Drug Resistance/International AIDS Society databases.Mothers (median age=24 years; 25/142 adolescents) were diagnosed during prenatal care (2008-2010) or previously (1994-2007). Recent cases were younger, mostly asymptomatic. Undetectable viremia and MTCT prophylaxis predominated in formerly diagnosed mothers. Recent cases had higher subtype C prevalence. One naive patient had transmitted resistance; ten antiretroviral-experienced patients had secondary resistance: 6 from MTCT prophylaxis, 4 under HAART. Late disclosure of diagnosis, vaginal delivery, breastfeeding, lack of oral zidovudine were observed in the three MTCT cases (3/149; 2.01%). Two of three infected infants harbored subtype C; infected infants/mothers did not have drug resistance mutations. Two of the transmitting-mothers had viremia <1000 copies/ml. Among exposed-uninfected infants the median time to seroreversion was 12 months.In this study delayed disclosure of diagnosis, partialo preventive measures, drug resistance among asymptomatic women under prophylaxis and MTCT in low viremic mothers raise concerns. The expansion of subtype C infection corroborates surveillance of HIV-1 diversity in this region.
机译:来自巴西中西部/戈亚斯州的一项高覆盖率的公共卫生产前计划(每年70,000名妇女)为早期诊断HIV-1和实施预防母婴传播的策略提供了独特的机会。为了对预期感染HIV-1的母亲/暴露婴儿队列中的MTCT进行调查。对142名母亲/他们的149婴儿(2008-2010年)进行了孕产妇病毒载量,CD4(+)细胞计数,HIV-1 pol序列的调查。婴儿的HIV-1 RNA检测(30/120天),顺序进行抗HIV-1 / 2血清学检测。 HIV-1亚型由REGA分配。通过校准的人口抗药性工具鉴定出已传播的药物抗药性,通过斯坦福大学HIV-1药物抗药性/国际艾滋病协会数据库鉴定为继发性抗药性。在产前检查期间(2008-2010年)诊断出母亲(中位年龄为24岁; 25/142名青少年)。或之前(1994-2007年)。最近的病例较年轻,多数无症状。在先前诊断的母亲中,无法检测到的病毒血症和MTCT预防居多。最近的病例具有较高的C型亚型患病率。一位天真的患者已经传播了抵抗力。十名接受抗逆转录病毒治疗的患者具有继发性耐药:预防MTCT有6例,在HAART下有4例。在3例MTCT病例中观察到了诊断的后期披露,阴道分娩,母乳喂养,缺乏口服齐多夫定(3/149; 2.01%)。三名受感染的婴儿中有两名携带C型。被感染的婴儿/母亲没有耐药性突变。两名传播母亲的病毒血症<1000份/毫升。在未感染的未感染婴儿中,血清还原的中位时间为12个月。在这项研究中,低病毒血症母亲的诊断延迟,部分/无预防措施,无症状孕妇的预防性耐药和MTCT引起了人们的关注。 C型感染的扩大证实了对该地区HIV-1多样性的监测。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号